Association of Improved Periconception Hemoglobin A1c With Pregnancy Outcomes in Women With Diabetes
Authors:
- 1 December 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (12) , e2030207
Abstract
Among women with prepregnancy diabetes , serum glycated hemoglobin A1c (HbA1c) provides a measure of mean blood glucose control over the preceding 90 days.1 Women with diabetes and an elevated preconception HbA1c are at higher risk of severe maternal morbidity (SMM),2 and their infants are more prone to congenital anomalies,3,4 especially cardiac malformations,5 as well as preterm birth and death.6Keywords
This publication has 31 references indexed in Scilit:
- HbA1c: A Review of Analytical and Clinical AspectsAnnals of Laboratory Medicine, 2013
- Pitfalls in Hemoglobin A1c Measurement: When Results may be MisleadingJournal of General Internal Medicine, 2013
- The long and winding road to optimal HbA1c measurementClinica Chimica Acta, 2013
- Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysisBMC Pregnancy and Childbirth, 2010
- Self-Efficacy Links Health Literacy and Numeracy to Glycemic ControlJournal of Health Communication, 2010
- Proliferation of prenatal ultrasonographyCanadian Medical Association Journal, 2010
- Review of hemoglobin A1c in the management of diabetesJournal of Diabetes, 2009
- The placenta in preterm birthJournal of Clinical Pathology, 2008
- Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1cBlood, 2008
- Use of Maternal GHb Concentration to Estimate the Risk of Congenital Anomalies in the Offspring of Women with Prepregnancy DiabetesDiabetes Care, 2007